有機化學人才網 | 最新人才 | 最新職位 | 技術交易 | 藥物合成 |
   
全站搜索: |
  您當前位置:網站首頁 >> 藥物合成路線圖解
 

藥物詳細合成路線

Name Spirapril;TI-211-950(hydrochloride);Sch-33844(HCl);Setrilan;Sandopril;Renormax
Chemical Name (8S)-7-[(S)-N-[(S)-1-Carboxy-3-phenylpropyl]alanyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid 1-ethyl ester
CAS 83647-97-6
Related CAS 94841-17-5 (HCl)
Formula C22H30N2O5S2
Structure
Formula Weight 466.6228
Stage 上市-1995
Company Essex (Originator), Novartis (Originator), Schering-Plough (Originator), Pfizer (Licensee)
Activity/Mechanism CARDIOVASCULAR DRUGS, Hypertension, Treatment of, Angiotensin-I Converting Enzyme (ACE) Inhibitors
Syn. Route 4
Route 1
a new synthesis of spirapril has been described:the cyclization of n-benzyloxycarbonyl-4-oxo-(s)-proline (i) with ethanedithiol by means of boron trifluoride ethearate in glacial acetic acid gives 7-(benzyloxycarbonyl)-1,4-dithia-7-azaspiro[4.4]nonane-8(s)-carboxylic acid (ii), which is deprotected with hbr in acetic acid to yield 1,4-dithia-7-azaspiro[4.4]nonane-8(s)-carboxylic acid (iii). this compound is then condensed with n-[1(s)-(ethoxycarbonyl)-3-phenylpropyl]-(s)-alanine (iv) by means of n-hydroxysuccinimide (nos) and 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide (dmcc) in dmf, or by means of n,n-disuccinimidyl carbonate and pyridine.
List of intermediates No.
tert-butyl 2-[[(1r)-2-[(2s)-2-([[(1s)-5-[[(benzyloxy)carbonyl]amino]-1-(1,3-thiazol-2-ylcarbonyl)pentyl]amino]carbonyl)pyrrolidinyl]-1-(cyclohexylmethyl)-2-oxoethyl](tert-butoxycarbonyl)amino]acetate (i)
1-methoxy-4-[(4-methoxyphenyl)disulfanyl]benzene; bis(4-methoxyphenyl) disulfide (ii)
4-methoxybenzenesulfinyl chloride (iii)
(1s,2r)-2-phenylcyclohexanol (iv)
Reference 1:
    swiss, g.f.; neustadt, b.r.; mcnamara, p.; baum, t.; smith, e.m.; gold, e.h.; sybertz, e.j.; angiotensin converting enzyme inhibitors: spirapril and related. j med chem 1989, 32, 7, 1600-6.

Route 2
a new synthesis of spirapril has been reported:the cyclization of n-benzyloxycarbonyl-4-oxo-(s)-proline (i) with ethandithiol by means of boron trifluoride ethearate in dichloromethane gives 7-(benzyloxycarbonyl)-1,4-dithia-7-azaspiro[4.4]nonane-8(s)-carboxylic acid (ii), which is treated with concentrated hcl to yield 1,4-dithia-7-azaspiro[4.4]nonane-8(s)-carboxylic acid (iii). the protection of (iii) with tert-butoxycarbonyl chloride and with trimethylsilylethanol in the usual manner affords n-(tert-butoxycarbonyl)-1,4-dithia-7-azaspiro[4.4]nonane-8(s)-carboxyli c acid 2-(trimethylsilyl)ethyl ester (iv), which is condensed with n-[1(s)-(ethoxycarbonyl)-3-phenylpropyl]-(s)-alanine (v) by a first treatment with p-toluenesulfonic acid and a condensation step with dicyclohexylcarbodiimide (dcc) and hydroxybenzotriazole (hbt), giving spirapril 2-(trimethylsilyl)ethyl ester (vi). finally, this ester is hydrolyzed with tetrabutylammonium fluoride trihydrate in dmf.
List of intermediates No.
tert-butyl 2-[[(1r)-2-[(2s)-2-([[(1s)-5-[[(benzyloxy)carbonyl]amino]-1-(1,3-thiazol-2-ylcarbonyl)pentyl]amino]carbonyl)pyrrolidinyl]-1-(cyclohexylmethyl)-2-oxoethyl](tert-butoxycarbonyl)amino]acetate (i)
1-methoxy-4-[(4-methoxyphenyl)disulfanyl]benzene; bis(4-methoxyphenyl) disulfide (ii)
4-methoxybenzenesulfinyl chloride (iii)
(1s,2r)-2-phenylcyclohexanol (v)
4-[(4-methoxyphenyl)sulfinyl]benzaldehyde (iv)
6-nitro-2,3-dihydro-4h-chromen-4-one (vi)
Reference 1:
    powell, j.r.; cushman, d.w.; krapcho, j.; turk, c.; deforrest, j.m.; spitzmiller, e.r.; karanewsky, d.s.; duggan, m.; rovnyak, g.; schwartz, j.; et al.; angiotensin-converting enzyme inhibitors. mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines. j med chem 1988, 31, 6, 1148.

Route 3
the cyclization of 1-benzyloxycarbonyl-4-oxoproline methyl ester (i) with ethanedithiol (ii) by means of p-toluenesulfonic acid in refluxing acetic acid gives methyl 7-benzyloxycarbonyl-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylate (iii), which is deprotected with 20% hbr to give methyl 1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylate (iv). the condensation of (iv) with n-benzyloxycarbonyl alanine n-hydroxysuccinimide ester (v) affords the corresponding dipeptide methyl ester (vi), which is hydrolyzed with naoh to the free acid (vii), and deprotected with 20% hbr as before to 7-alanyl-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid (viii). finally, this compound is condensed with ethyl 2-oxo-4-phenylbutyrate (ix) by means of sodium cyanoborohydride in methanol.
List of intermediates No.
2-(4-[[(e)-benzylidene]amino]phenyl)butanenitrile (ix)
ethyl 3-bromo-4-hydroxy-5-iodobenzoate (i)
ethyl 3-bromo-4-(2-hydroxyethoxy)-5-iodobenzoate (ii)
3-chlorophenylboronic acid (a)
(iii)
(iv)
2,3,3a,4,5,6-hexahydro-1h-phenalen-1-one oxime (v)
(vi)
8-(7,8,9,9a-tetrahydro-1h-phenalen-3-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (vii)
(3r)-3-(palmitoyloxy)tetradecanoic acid (viii)
Reference 1:
    smith, e.m.; neustadt, b.r.; gold, e.h. (schering corp.); 7-carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids. jp 1989163197; us 4470972 .
Reference 2:
    prous, j.; castaner, j.; spirapril. drugs fut 1987, 12, 9, 860.

Route 4
the condensation of (ix) with alanine benzyl ester (x) with sodium cyanoboohydride as before gives n-[1-(ethoxycarbonyl)-3-phenylpropyl]alanine benzyl ester (xi), which is submitted to fractional crystallization with maleic acid yielding n-[1(s)-(ethoxycarbonyl)-3-phenylpropyl]-(s)-alanine benzyl ester (xii), which is debenzylated by hydrogenation with h2 over pd/c in ethanol yielding the free acid (xiii). finally, this compound is condensed with spirane (iv) through the n-hydroxysuccinimide ester, in the usual way.
List of intermediates No.
1-(2-fluoro[1,1-biphenyl]-4-yl)-1-propanone (x)
(1s,2r)-2-phenylcyclohexanol (xiii)
2-[4-(4-chlorophenyl)-1-(4-fluorophenyl)-1h-pyrazol-3-yl]acetonitrile (xii)
2-(4-[[(e)-benzylidene]amino]phenyl)butanenitrile (ix)
methyl 1-methyl-5-nitro-1h-imidazol-2-yl sulfide; 1-methyl-2-(methylsulfanyl)-5-nitro-1h-imidazole (a)
(iv)
(1r)-1-(2-[[(4ar,6r,7r,8r,8as)-6-(benzyloxy)-8-hydroxy-2,2-dimethylhexahydropyrano[3,2-d][1,3]dioxin-7-yl]amino]-2-oxoethyl)dodecyl palmitate (xi)
Reference 1:
    smith, e.m.; neustadt, b.r.; gold, e.h. (schering corp.); 7-carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids. jp 1989163197; us 4470972 .
Reference 2:
    prous, j.; castaner, j.; spirapril. drugs fut 1987, 12, 9, 860.

來源:藥化網

作者:藥化小編

摘要:本文合成路線介紹的是藥物中文名螺普利;英文名Spirapril;TI-211-950(hydrochloride);Sch-33844(HCl);Setrilan;Sandopril;Renormax;CAS[83647-97-6]

 
推薦VIP企業
無錫景耀生物科技有限公司
杭州盧普生物科技有限公司
寧波賽倫化工有限公司
蘇州昊賽生物科技有限公司
北京嘉盛揚醫藥科技有限公司
上海澤涵生物醫藥科技有限公司
河北固安三利化工公司
鄭州凱普瑞生物技術有限公司
上海藥谷藥業有限公司
蘭州康寓信生物科技有限公司
湖北朗昕生化藥業有限公司
武漢福鑫化工有限公司
嘉興市英南化工有限公司
蘇州迪飛醫藥科技有限公司
唐山盛源澤興化工有限公司
上海盛中醫藥化工有限公司
連云港天和化學有限公司
南京晨瑞醫藥科技有限公司
南京蘇如化工有限公司
常州瑞盛化工有限公司
熱門文章
作物保護領域新熱點——植物生物
第15批!通過認定的農藥登記試
海利爾獲“金質量·持續成長獎”
安道麥推出新產品,并將致力于完
失效農藥如何鑒別?過期農藥如何
新修訂發布的《產業結構調整指導
麥田雜草發生加重,春季化除壓力
涉及21家農化企業,山東省公布
這29條環境違法行為可舉報!獎
10年時間成為大豆殺菌劑市場領
全球食品安全指數:中國進步明顯
2018年我國農藥標準發布概況
山東省農作物病蟲預報:小麥/玉
檢察機關:農資打假絕不手軟!
全國農技推廣中心:小麥條銹病發
土壤調理劑市場規模已達482億
2019農業令人矚目十大事件!
因抗藥性,這些農藥已失效了,怎
立足預防,主動出擊,全面做好油
中農立華+紅太陽,市場占有率或
 友情鏈接
有機化學人才網  
首頁 | 廣告服務 | 建站服務 | 關于我們 | 聯系我們 | 版權聲明
在手机上赚钱的有哪些方法